Quick Answer
Orchestra BioMed Holdings, Inc. reported Stockholders Equity of -$6.94 million for the year ending 2022.
- Orchestra BioMed Holdings, Inc. showed a decrease of -76.2% in Stockholders Equity from 2021 to 2022.
- This data is from Orchestra BioMed Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on January 25, 2023.
- XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $13.5 thousand | Q3 2020: -$3.47 million | Q1 2021: -$3.67 million | Q2 2021: -$3.76 million | Q3 2021: -$3.85 million | Q4 2021: -$19.78 million | Q1 2022: $78.0 thousand | Q2 2022: -$5.25 million | Q3 2022: -$6.07 million | Q4 2022: $52.54 million | Q1 2023: $99.75 million.
- Over the full 3 years of available data (2020 to 2022), Orchestra BioMed Holdings, Inc.'s Stockholders Equity has declined by 94.9%.
- Historical annual values: Fiscal year 2022: -$6.94 million | Fiscal year 2021: -$3.94 million | Fiscal year 2020: -$3.56 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: